SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 125 filers reported holding SUTRO BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,647 | -25.4% | 10,561 | 0.0% | 0.01% | -28.6% |
| Q2 2023 | $49,109 | +0.6% | 10,561 | 0.0% | 0.01% | +16.7% |
| Q1 2023 | $48,792 | -42.8% | 10,561 | 0.0% | 0.01% | -53.8% |
| Q4 2022 | $85,333 | +44.6% | 10,561 | 0.0% | 0.01% | +30.0% |
| Q3 2022 | $59,000 | +7.3% | 10,561 | 0.0% | 0.01% | +11.1% |
| Q2 2022 | $55,000 | -36.8% | 10,561 | 0.0% | 0.01% | -30.8% |
| Q1 2022 | $87,000 | -44.6% | 10,561 | 0.0% | 0.01% | -38.1% |
| Q4 2021 | $157,000 | -21.1% | 10,561 | 0.0% | 0.02% | -22.2% |
| Q3 2021 | $199,000 | +1.5% | 10,561 | 0.0% | 0.03% | 0.0% |
| Q2 2021 | $196,000 | -18.3% | 10,561 | 0.0% | 0.03% | -25.0% |
| Q1 2021 | $240,000 | +4.8% | 10,561 | 0.0% | 0.04% | +2.9% |
| Q4 2020 | $229,000 | – | 10,561 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |